Elisabeth Bendstrup

Bronchoscopic lung volumen reduction is a treatment offered to patients with severe heterogenous emphysema

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Standard

Bronchoscopic lung volumen reduction is a treatment offered to patients with severe heterogenous emphysema. / Bendstrup, Elisabeth; Hilberg, Ole.

In: Ugeskrift for Laeger, Vol. 176, No. 18, 28.04.2014.

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{56f9bca8177d475abef472b529c4b929,
title = "Bronchoscopic lung volumen reduction is a treatment offered to patients with severe heterogenous emphysema",
abstract = "Idiopathic pulmonary fibrosis is a chronic, progressive interstitial pneumonia of unknown cause. It occurs primarily in older patients and is limited to the lungs. The prognosis is poor with a median survival of 2-3 years after diagnosis. The diagnosis is based on a definite pattern of usual interstitial pneumonia on high resolution computed tomography or specific combinations of radiological and histopathological patterns. All patients should be evaluated for lung transplantation, and treatment with the anti-fibrotic drug pirfenidone is recommended for patients with a forced vital capacity > 50% and a lung diffusion capacity > 35%.",
author = "Elisabeth Bendstrup and Ole Hilberg",
year = "2014",
month = apr,
day = "28",
language = "English",
volume = "176",
journal = "Ugeskrift for L{\ae}ger ",
issn = "0041-5782",
publisher = "Den Almindelige Danske L{\ae}geforening",
number = "18",

}

RIS

TY - JOUR

T1 - Bronchoscopic lung volumen reduction is a treatment offered to patients with severe heterogenous emphysema

AU - Bendstrup, Elisabeth

AU - Hilberg, Ole

PY - 2014/4/28

Y1 - 2014/4/28

N2 - Idiopathic pulmonary fibrosis is a chronic, progressive interstitial pneumonia of unknown cause. It occurs primarily in older patients and is limited to the lungs. The prognosis is poor with a median survival of 2-3 years after diagnosis. The diagnosis is based on a definite pattern of usual interstitial pneumonia on high resolution computed tomography or specific combinations of radiological and histopathological patterns. All patients should be evaluated for lung transplantation, and treatment with the anti-fibrotic drug pirfenidone is recommended for patients with a forced vital capacity > 50% and a lung diffusion capacity > 35%.

AB - Idiopathic pulmonary fibrosis is a chronic, progressive interstitial pneumonia of unknown cause. It occurs primarily in older patients and is limited to the lungs. The prognosis is poor with a median survival of 2-3 years after diagnosis. The diagnosis is based on a definite pattern of usual interstitial pneumonia on high resolution computed tomography or specific combinations of radiological and histopathological patterns. All patients should be evaluated for lung transplantation, and treatment with the anti-fibrotic drug pirfenidone is recommended for patients with a forced vital capacity > 50% and a lung diffusion capacity > 35%.

M3 - Journal article

C2 - 25351567

VL - 176

JO - Ugeskrift for Læger

JF - Ugeskrift for Læger

SN - 0041-5782

IS - 18

ER -